119 related articles for article (PubMed ID: 19154704)
1. [In silico, in vitro, in omic experimental models and drug safety evaluation].
Claude N; Goldfain-Blanc F; Guillouzo A
Med Sci (Paris); 2009 Jan; 25(1):105-10. PubMed ID: 19154704
[TBL] [Abstract][Full Text] [Related]
2. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. In silico methods for early toxicity assessment.
Merlot C
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
7. Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals.
Claude JR; Claude N
Toxicol Lett; 2004 Jun; 151(1):25-8. PubMed ID: 15177637
[TBL] [Abstract][Full Text] [Related]
8. Computational science in drug metabolism and toxicology.
Valerio LG
Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
[TBL] [Abstract][Full Text] [Related]
9. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here?
Stevens JL
Chem Res Toxicol; 2006 Nov; 19(11):1393-401. PubMed ID: 17112225
[TBL] [Abstract][Full Text] [Related]
10. A structural feature-based computational approach for toxicology predictions.
Valerio LG; Yang C; Arvidson KB; Kruhlak NL
Expert Opin Drug Metab Toxicol; 2010 Apr; 6(4):505-18. PubMed ID: 20074001
[TBL] [Abstract][Full Text] [Related]
11. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
12. Three Rs potential in the development and quality control of pharmaceuticals.
Hartung T
ALTEX; 2001; 18 Suppl 1():3-13. PubMed ID: 11854852
[TBL] [Abstract][Full Text] [Related]
13. Concise review: Human pluripotent stem cell-based models for cardiac and hepatic toxicity assessment.
Sartipy P; Björquist P
Stem Cells; 2011 May; 29(5):744-8. PubMed ID: 21433222
[TBL] [Abstract][Full Text] [Related]
14. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
Jacobson-Kram D; Contrera JF
Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
[TBL] [Abstract][Full Text] [Related]
15. Future of toxicology--low-dose toxicology and risk--benefit analysis.
Rietjens IM; Alink GM
Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
[TBL] [Abstract][Full Text] [Related]
16. Computational toxicology in drug development.
Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
[TBL] [Abstract][Full Text] [Related]
17. The inspection of drug metabolism and pharmacokinetic studies.
Dent NJ
Qual Assur; 1992 Jun; 1(3):230-6. PubMed ID: 1344678
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
Baillie TA
Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
[TBL] [Abstract][Full Text] [Related]
19. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
Box RJ; Spielmann H
Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
[TBL] [Abstract][Full Text] [Related]
20. Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products.
Kruhlak NL; Contrera JF; Benz RD; Matthews EJ
Adv Drug Deliv Rev; 2007 Jan; 59(1):43-55. PubMed ID: 17229485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
